Argus

•

Mar 26, 2026

Symbols

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$126.32

Price Target

Summary

Illumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics, and consumer genomics businesses.

The company's portfolio of products and services is designed to accelerate and simplify genetic analysis. Illumina also invests

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

A: Raising target price to $126.00

Mar 25, 2026

•

A

ALGN: Raising target price to $201.00

Mar 25, 2026

•

ALGN

BMRN: Lowering target price to $60.00

Mar 25, 2026

•

BMRN

TRUP: Lowering target price to $24.00

Mar 25, 2026

•

TRUP

IDXX: Lowering target price to $627.00

Mar 25, 2026

•

IDXX

Sign in to access your portfolio